[go: up one dir, main page]

WO2001049273A3 - Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff - Google Patents

Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff Download PDF

Info

Publication number
WO2001049273A3
WO2001049273A3 PCT/EP2000/013268 EP0013268W WO0149273A3 WO 2001049273 A3 WO2001049273 A3 WO 2001049273A3 EP 0013268 W EP0013268 W EP 0013268W WO 0149273 A3 WO0149273 A3 WO 0149273A3
Authority
WO
WIPO (PCT)
Prior art keywords
additive
pharmaceutical composition
hormones
transdermally administering
enhances permeation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/013268
Other languages
English (en)
French (fr)
Other versions
WO2001049273A2 (de
Inventor
Achim Berthold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Priority to AU23698/01A priority Critical patent/AU2369801A/en
Publication of WO2001049273A2 publication Critical patent/WO2001049273A2/de
Publication of WO2001049273A3 publication Critical patent/WO2001049273A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Eine pharmazeutische Zusammensetzung zur transdermalen Verabreichung eines oder mehrerer Hormone, haftklebend auf der Haut zu befestigen, mit mindestens einer hormonhaltigen Matrixschicht, einen die Hautpermeation verbessernden Zusatzstoff enthaltend, ist dadurch gekennzeichnet, daß der genannte Zusatzstoff eine 1,4-Dioxan-2,5-dion-Grundstruktur der allgemeinen Formel (I) aufweist, wobei die Reste R1 und R2 Kohlenwasserstoffgruppen oder substituierte Kohlenwasserstoffgruppen oder funktionelle Gruppen sind.
PCT/EP2000/013268 2000-01-07 2000-12-23 Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff Ceased WO2001049273A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU23698/01A AU2369801A (en) 2000-01-07 2000-12-23 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000100333 DE10000333A1 (de) 2000-01-07 2000-01-07 Pharmazeutische Zusammensetzung zur transdermalen Verabreichung von Hormonen mit einem permeationsverbessernden Zusatzstoff
DE10000333.8 2000-01-07

Publications (2)

Publication Number Publication Date
WO2001049273A2 WO2001049273A2 (de) 2001-07-12
WO2001049273A3 true WO2001049273A3 (de) 2002-05-23

Family

ID=7626866

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/013268 Ceased WO2001049273A2 (de) 2000-01-07 2000-12-23 Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff

Country Status (4)

Country Link
AR (1) AR026797A1 (de)
AU (1) AU2369801A (de)
DE (1) DE10000333A1 (de)
WO (1) WO2001049273A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873371B1 (fr) * 2004-07-26 2008-07-04 Sod Conseils Rech Applic Nouvelle methode de synthese de 2,5 dioxane 1,4 diones
DE102006050558B4 (de) * 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
DE102010004769A1 (de) 2009-07-08 2011-01-13 Kuchenbecker, Manfred, Dr.-Ing. Reluktanzgenerator
EP2812372B1 (de) 2012-02-09 2018-09-26 Novus International Inc. Heteroatom mit cyclischen dimeren
US9452143B2 (en) 2012-07-12 2016-09-27 Novus International, Inc. Matrix and layer compositions for protection of bioactives
KR20160040207A (ko) 2013-08-09 2016-04-12 더 케무어스 컴퍼니 에프씨, 엘엘씨 환형 다이에스테르를 갖는 피부 케어 조성물 및 이의 방법
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003119A1 (en) * 1994-07-26 1996-02-08 Lavipharm S.A. Transdermal delivery device containing an estrogen
WO1996040087A2 (en) * 1995-06-07 1996-12-19 Cygnus, Inc. Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003119A1 (en) * 1994-07-26 1996-02-08 Lavipharm S.A. Transdermal delivery device containing an estrogen
WO1996040087A2 (en) * 1995-06-07 1996-12-19 Cygnus, Inc. Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group

Also Published As

Publication number Publication date
AR026797A1 (es) 2003-02-26
DE10000333A1 (de) 2001-07-19
AU2369801A (en) 2001-07-16
WO2001049273A2 (de) 2001-07-12

Similar Documents

Publication Publication Date Title
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
WO2004060405A8 (en) Tissue reactive compounds and compositions and uses thereof
AU5049498A (en) Use of 1-benzyl-3-(substituted hetaryl)-fused pyrazole derivatives for the treatment of specific disorders of the cardiovascular system and of the central nervous system
EP1561461A3 (de) Klebstoffmasse zur transdermalen Verabreichung von stark weichmachenden Wirkstoffen
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
WO2003018004A3 (en) Analgetic pyrroline derivatives
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DE69226624D1 (de) Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
ATE244558T1 (de) Trockene formbare arzneistoffformulierung
WO2004060315A3 (en) Stable topical drug delivery compositions
BRPI0307777B8 (pt) emplastro transdérmico
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
WO2005110417A8 (en) Phycotoxins and uses thereof
WO2001049273A3 (de) Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff
KR900005978A (ko) 키니딘, 아르테미시닌 및 이의 유도체를 사용한 항말라리아 조성물 및 치료방법
FI953377L (fi) Fosfatointikoostumuksia ja -menetelmiä, erityisesti käytettäviksi painettujen piirien valmistuksessa, jossa hyödynnetään orgaanisia resistejä
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
DK1135163T3 (da) Topiske sammensætninger indeholdende ascomyciner
PL320915A1 (en) Derivatives of piperasino-2,5-dione as modulators of drug-fasteness in respect to many drugs
BR8904152A (pt) Composicao,composicao curavel,verniz de laminacao,substrato,laminado e composicao de agente de cura
EP1023901A4 (de) Heilmittel für hepatitis c und dessen verwendung
ATE218858T1 (de) C9 taxanderivate und diese enthaltende pharmazeutische zusammensetzungen
DE60105028D1 (de) Ruthenium (ii) verbindungen in der krebsbehandlung
SE0103795D0 (sv) Compounds and method for the treatment of överactive bladder
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN JP KR MX US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN JP KR MX US ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP